![]() |
|
|
Vol. 290, Issue 3, 1048-1053, September 1999
Heymans Institute of Pharmacology (P. De P., F.M.B.), The influence of hypovolemia (removal of 30% of the blood volume) on
the pharmacokinetics and pharmacodynamics of etomidate was investigated
in the rat. Chronically instrumented animals were randomly allocated to
either a control (n = 9) or a hypovolemia (n = 9) group, and etomidate was infused (50 mg/kg/h) until isoelectric periods of 5 s or longer were observed
in the electroencephalogram. The changes observed in the
electroencephalogram were quantified using aperiodic analysis in the
2.5- to 7.5-Hz frequency band and used as a surrogate measure of
hypnosis. The righting reflex was used as a clinical measure of
hypnosis. The etomidate dose that had to be infused to reach the
electroencephalographic endpoint was almost 40% lower
(p < .01) in the hypovolemic animals than in the
control animals. This difference could be attributed to a decrease in
clearance (
20%; p = .06) and distribution volume (
30%; p < .01) of etomidate. Protein binding
was similar in both groups. To investigate changes in end organ
sensitivity during hypovolemia, the electroencephalographic
effect-versus-effect-site concentration relationship was
studied. The effect-plasma concentration relationship was biphasic,
exhibiting profound hysteresis in both hypovolemic and control animals.
Semiparametric minimization of this hysteresis revealed similar
equilibrium half-lives in both groups, and the biphasic
effect-concentration relationship was characterized nonparametrically
by descriptors. With these descriptors, a slightly increased potency of
etomidate during hemorrhage was observed. The concentration at the
return of righting reflex was 16% (p < .05) lower
in the hypovolemic animals. In conclusion, an increased hypnotic effect
of etomidate was observed during hypovolemia that is mainly attributed
to pharmacokinetic changes. Our data also suggest a small increase in
central nervous system sensitivity for etomidate in hypovolemic animals.
0022-3565/99/2903-1048$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics
This article has been cited by other articles:
![]() |
T. Kurita, K. Takata, M. Uraoka, K. Morita, Y. Sanjo, T. Katoh, and S. Sato The Influence of Hemorrhagic Shock on the Minimum Alveolar Anesthetic Concentration of Isoflurane in a Swine Model Anesth. Analg., December 1, 2007; 105(6): 1639 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, M. J. Laster, E. I. Eger II, M. Sharma, and J. M. Sonner Blockade of Acetylcholine Receptors Does Not Change the Dose of Etomidate Required to Produce Immobility in Rats Anesth. Analg., April 1, 2007; 104(4): 850 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marchand, C. Dahyot, I. Lamarche, E. Plan, O. Mimoz, and W. Couet Lack of Effect of Experimental Hypovolemia on Imipenem Muscle Distribution in Rats Assessed by Microdialysis Antimicrob. Agents Chemother., December 1, 2005; 49(12): 4974 - 4979. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Limosin, A. Dupuis, I. Lamarche, O. Mimoz, J. Paquereau, and W. Couet Pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of imipenem in rats with experimental hypovolaemia or endotoxaemia J. Antimicrob. Chemother., July 1, 2004; 54(1): 187 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Johnson, T. D. Egan, J. Layman, S. E. Kern, J. L. White, and S. W. McJames The Influence of Hemorrhagic Shock on Etomidate: A Pharmacokinetic and Pharmacodynamic Analysis Anesth. Analg., May 1, 2003; 96(5): 1360 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kuizenga, J. M. K. H. Wierda, and C. J. Kalkman Biphasic EEG changes in relation to loss of consciousness during induction with thiopental, propofol, etomidate, midazolam or sevoflurane Br. J. Anaesth., March 1, 2001; 86(3): 354 - 360. [Abstract] [Full Text] [PDF] |
||||